. 2017 Jun;38(6):505–510. [Article in Chinese] doi: 10.3760/cma.j.issn.0253-2727.2017.06.008
2017年版权归中华医学会所有
Copyright © 2017 by Chinese Medical Association
This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
图1. 是否接受利妥昔单抗治疗（A）及是否为黏膜相关淋巴组织淋巴瘤转化的弥漫大B细胞淋巴瘤（DLBCL）（B）对原发胃DLBCL患者无进展生存的影响.
